Noteworthy - Pharmaceutical Executive



Sickle Cell Disease In Three Acts

April 22, 2014

Ben Comer reports on how new pipeline therapies, public research investments, and a renewed sociopolitical focus are working toward a happier outcome for sickle cell disease patients.

Regional Trends in Bioinnovation Investment

April 16, 2014

California's Bay Area and the Boston/Cambridge nexus continue to dominate bioinnovation in the US. Pharm Exec looks at the factors contributing to the strategic dominance of these regions.

Fixing Wikipedia

April 10, 2014

Will Pharma join a growing effort to make the world's leading online health information resource more relevant to providers and safer for patients? Peter Houston reports.

European Clinical Trials: The Die Is Cast

April 15, 2014

Politicians and health campaigners are celebrating the final agreement of the EU's new clinical trials rules. But the European drug industry is not so euphoric, writes Reflector.

HBA's Women of the Year 2014

April 10, 2014

The Healthcare Businesswomen's Association honored three female leaders this year. We take an in-depth look at each winner's background and career—and what factors helped push them to the top of their game.

Obama Policies Reshape Pharma Marketing

April 10, 2014

Health reform initiatives promote transparency, challenge reimbursement, writes Jill Wechsler.

The FORUM Format

April 7, 2014

With a new name and a veteran CEO, Deborah Dunsire, at the helm, FORUM Pharmaceuticals's flag is waving high in the increasingly solitary struggle against CNS disease.

"Market-Based" Price Controls in India?

April 2, 2014

Ram Subramanian, Nikhil Mutyal and Emma Nechamkin outline three strategic implications for pharma pricing strategies in India

Musings from the Conference Circuit: A Wake-up Call for Pharma

March 28, 2014

Bill Drummy reports on the key healthcare takeaways from this year's South by Southwest (SXSW) Interactive conference in Austin, Texas.


Click here